Here, we report a short protocol for the digestion of meningioma tissue into a single-cell suspension that contains viable immune cells that comprise of predominantly CD14+ macrophages, CD3+ T cells, and to a lesser extent CD56+ natural killer (NK) cells, and CD19+ B cells. The gene discussed is CD14; the disease is meningioma.